Abbott Labs Shares Rise After Profit Tops Forecasts

Shares of Abbott Laboratories rose 1.7% in light premarket trade Wednesday, after the drug maker reported better-than-expected third-quarter profit, and lifted the midpoint of its full-year outlook, citing an improved performance in its branded generic pharmaceuticals and nutrition businesses.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.